Search Results
Anton Hagenbeek | EHA 2018 | Relevant findings of the RELEVANCE phase III study
Anton Hagenbeek | EHA 2018 | Relevante bevindingen van de RELEVANCE fase III-studie
Prof. Anton Hagenbeek case study presentation
Prof Anton Hagenbeek at ASH 2014: Good news for the management of lymphoma
Prof. Hagenbeek discusses brentuximan vedotin advances in HL and DLBCL revealed at 13-ICML
Niels Van de Donk | EHA 2018 | Immunotherapy in myeloma: why, when and how?
RELEVANCE study: the R-squared regimen for follicular lymphoma
Martin Hutchings | EHA 2018 | Key outcomes of the ECHELON-1 sub-analysis
Advanced Hodgkin lymphoma: AHL2011 data update from EHA 2018
What should the future of cancer treatment and research look like?
Small, smart molecules in cancer treatment - Prof Hagenbeek
Comment on pregnancy outcomes in patients with chronic myeloid leukaemia
